FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2087576129> ?p ?o ?g. }

• W2087576129 endingPage "3163" @default.
• W2087576129 startingPage "3158" @default.
• W2087576129 abstract "1. Following our earlier observations that the tachykinin NK1 receptor antagonist CP-99,994 is an effective anti-emetic in ferrets, we have examined the anti-emetic effects of a more potent and novel NK1 receptor antagonist, GR203040, against various emetic stimuli in the ferret, dog and house musk shrew (Suncus murinus). 2. In ferrets, GR203040 (0.1 mg kg-1 s.c. or i.v.) is effective against emesis induced by radiation, cisplatin, cyclophosphamide, copper sulphate, ipecacuanha or morphine. 3. In animals in which emesis had been established with cisplatin, GR203040 (1 mg kg-1 s.c.) was fully effective as an interventional treatment. No further emesis was seen in animals treated with GR203040 whilst saline-treated animals continued to vomit. 4. GR203040 (0.1 mg kg-1 s.c.) retains anti-emetic efficacy in the ferret, even when given as a 6 h pretreatment, indicating that this compound has a long duration of action. The compound is also effective orally at the same dose, when given as a 90 min pretreatment. 5. GR203040 (0.1 mg kg-1 i.v.) is fully effective against ipecacuanha-induced emesis in the dog. 6. GR203040 is effective against motion- and cisplatin-induced emesis in Suncus murinus. These effects were seen at doses an order of magnitude greater than those shown to be effective against cisplatin in the ferret. 7. In conclusion, GR203040 is a novel anti-emetic agent, and the broad spectrum of anti-emetic activity, together with activity observed in three species, suggests that this compound is worthy of clinical investigation." @default.
• W2087576129 created "2016-06-24" @default.
• W2087576129 creator A5002292544 @default.
• W2087576129 creator A5011094465 @default.
• W2087576129 creator A5027281189 @default.
• W2087576129 creator A5029549096 @default.
• W2087576129 creator A5037019629 @default.
• W2087576129 creator A5052181080 @default.
• W2087576129 creator A5052829050 @default.
• W2087576129 creator A5056771320 @default.
• W2087576129 date "1995-12-01" @default.
• W2087576129 modified "2023-10-15" @default.
• W2087576129 title "The broad‐spectrum anti‐emetic activity of the novel non‐peptide tachykinin NK₁ receptor antagonist GR203040" @default.
• W2087576129 cites W127429958 @default.
• W2087576129 cites W1853525790 @default.
• W2087576129 cites W1963685566 @default.
• W2087576129 cites W1966546066 @default.
• W2087576129 cites W1976420709 @default.
• W2087576129 cites W1980183883 @default.
• W2087576129 cites W1983413945 @default.
• W2087576129 cites W2001861109 @default.
• W2087576129 cites W2008330001 @default.
• W2087576129 cites W2012443772 @default.
• W2087576129 cites W2046581354 @default.
• W2087576129 cites W2060265337 @default.
• W2087576129 cites W2062465200 @default.
• W2087576129 cites W2069215198 @default.
• W2087576129 cites W2072171815 @default.
• W2087576129 cites W2073291528 @default.
• W2087576129 cites W2073893855 @default.
• W2087576129 cites W2118883064 @default.
• W2087576129 cites W2156198012 @default.
• W2087576129 cites W2415824472 @default.
• W2087576129 doi "https://doi.org/10.1111/j.1476-5381.1995.tb15118.x" @default.
• W2087576129 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1909155" @default.
• W2087576129 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8719790" @default.
• W2087576129 hasPublicationYear "1995" @default.
• W2087576129 type Work @default.
• W2087576129 sameAs 2087576129 @default.
• W2087576129 citedByCount "111" @default.
• W2087576129 countsByYear W20875761292012 @default.
• W2087576129 countsByYear W20875761292013 @default.
• W2087576129 countsByYear W20875761292014 @default.
• W2087576129 countsByYear W20875761292015 @default.
• W2087576129 countsByYear W20875761292016 @default.
• W2087576129 countsByYear W20875761292017 @default.
• W2087576129 countsByYear W20875761292018 @default.
• W2087576129 countsByYear W20875761292023 @default.
• W2087576129 crossrefType "journal-article" @default.
• W2087576129 hasAuthorship W2087576129A5002292544 @default.
• W2087576129 hasAuthorship W2087576129A5011094465 @default.
• W2087576129 hasAuthorship W2087576129A5027281189 @default.
• W2087576129 hasAuthorship W2087576129A5029549096 @default.
• W2087576129 hasAuthorship W2087576129A5037019629 @default.
• W2087576129 hasAuthorship W2087576129A5052181080 @default.
• W2087576129 hasAuthorship W2087576129A5052829050 @default.
• W2087576129 hasAuthorship W2087576129A5056771320 @default.
• W2087576129 hasBestOaLocation W20875761291 @default.
• W2087576129 hasConcept C118303440 @default.
• W2087576129 hasConcept C126322002 @default.
• W2087576129 hasConcept C134018914 @default.
• W2087576129 hasConcept C170493617 @default.
• W2087576129 hasConcept C185592680 @default.
• W2087576129 hasConcept C202871150 @default.
• W2087576129 hasConcept C2776533618 @default.
• W2087576129 hasConcept C2776694085 @default.
• W2087576129 hasConcept C2776885963 @default.
• W2087576129 hasConcept C2778122271 @default.
• W2087576129 hasConcept C2778169610 @default.
• W2087576129 hasConcept C2778239845 @default.
• W2087576129 hasConcept C2780852908 @default.
• W2087576129 hasConcept C2780884295 @default.
• W2087576129 hasConcept C71924100 @default.
• W2087576129 hasConcept C86803240 @default.
• W2087576129 hasConcept C98274493 @default.
• W2087576129 hasConceptScore W2087576129C118303440 @default.
• W2087576129 hasConceptScore W2087576129C126322002 @default.
• W2087576129 hasConceptScore W2087576129C134018914 @default.
• W2087576129 hasConceptScore W2087576129C170493617 @default.
• W2087576129 hasConceptScore W2087576129C185592680 @default.
• W2087576129 hasConceptScore W2087576129C202871150 @default.
• W2087576129 hasConceptScore W2087576129C2776533618 @default.
• W2087576129 hasConceptScore W2087576129C2776694085 @default.
• W2087576129 hasConceptScore W2087576129C2776885963 @default.
• W2087576129 hasConceptScore W2087576129C2778122271 @default.
• W2087576129 hasConceptScore W2087576129C2778169610 @default.
• W2087576129 hasConceptScore W2087576129C2778239845 @default.
• W2087576129 hasConceptScore W2087576129C2780852908 @default.
• W2087576129 hasConceptScore W2087576129C2780884295 @default.
• W2087576129 hasConceptScore W2087576129C71924100 @default.
• W2087576129 hasConceptScore W2087576129C86803240 @default.
• W2087576129 hasConceptScore W2087576129C98274493 @default.
• W2087576129 hasIssue "8" @default.
• W2087576129 hasLocation W20875761291 @default.
• W2087576129 hasLocation W20875761292 @default.
• W2087576129 hasLocation W20875761293 @default.
• W2087576129 hasLocation W20875761294 @default.
• W2087576129 hasOpenAccess W2087576129 @default.

• next